The MINICAP FLEX-PIERCING instrument offers flexibility for small size laboratories. The fully automated instrument meets the needs of the laboratory while providing clear-cut and precise separations utilizing capillary electrophoresis technology. This multi-parameter, compact, automated capillary electrophoresis instrument offers a comprehensive menu on serum and whole blood for Protein, Immunotyping, HbA1c and CDT (Carbohydrate Deficient Transferrin) testing.
For whole blood testing, the capped tubes are gently inverted to ensure adequate mixing of the samples providing accurate results. The instrument provides complete walk-away automation reducing overall labor requirements.
Sebia condensed its experience in a compact and fully featured instrument, with the same resolution as its CAPILLARYS 3 OCTA and TERA Instruments.
4 capillary electrophoresis techniques are available on this compact platform.
Sample types: whole blood, serum
This compact bench instrument can process up to 28 samples in one go (26 on HbA1c and CDT), fully automated and allowing continuous loading.
Throughput (tests/hour)* System autonomy (minutes)
PROTEIN(E) 6 (serum) 20 84
IMMUNOTYPING (serum) 1.7 988
Hb A1c 7 240
CDT 10 168
* Using Software version 9.30
High throughput Serum Protein Electrophoresis with high resolution results.
Fully automated monoclonal proteins identification by Capillarys electrophoresis.
The most reliable chronic alcohol abuse marker.
Understand in 2 minutes how capillary electrophoresis works, and why it gives such high and clear resolution in lab testing.
Interview between Sebia and M. Jean Deenmamode, CDT IFCC Working Group Chair
IFCC Standardisation of the Sebia CDT measurement on CAPILLARYS 3 TERA.
HbA1c is routinely used in the clinical laboratory to diagnose and monitor diabetes mellitus. Many methods have been standardized to provide precise and accurate results for normal patients. For the other common Hb variants, most of the methods are now relatively free of analytical interference.
Educational Webinar with David G. Grenache, PhD, D(ABCC)
Chief Scientific Officer, TriCore Reference Laboratories
CDT is a sensitive and specific marker of chronic alcohol abuse, used in several contexts and notably including forensic settings, industries, clinical applications.
Sebia specializes in providing testing solutions for a range of diseases, including Diabetes and Multiple Myeloma. Learn about the impact of these diseases and the medical solutions available.
Educational Webinar with Dr. Barbara De la Salle
The EurA1c trial, organized yearly, investigates the performance of HbA1c assays across countries and manufacturers.
This article assesses the performances of the different manufacturers and technologies (HPLC and CE) for Hb A2 measurement using both International Reference Reagent for HbA2 (WHO IRR 89/666) and analysis of three whole blood specimens over a range of HbA2, distributed to 56 laboratories located in 14 different countries.
This article reminds the reader of the importance of detecting the Hb variants when measuring HbA1c for the labs and clinicians to better interpret the results and to ensure optimal management of the diabetic patient.
Hemoglobin C, D Punjab, E or S trait can interfere with hemoglobin A1c (HbA1c) results depending on the method of analysis used. Therefore, it is important to know the limitations of the method used for HbA1c determination.
Article from Jean Deenmamode, IFCC CDT working group chair in CLI magazine.
IFCC CDT-Working Group standardized the CDT measurement.
This section contains information intended for wide distribution and may therefore contain product details or information that is not available or valid in your country.
Please contact your local Sebia representative. Information intended for healthcare professionals.
Carefully read the instructions in the reagent package inserts and instrument manuals.